Johann Wagner
Affiliations: | Vienna University, Austria |
Area:
Pathological anatomyGoogle:
"Johann Wagner"Bio:
(ca. 1800 - 1833)
http://www.deutsche-biographie.de/sfz84231.html
https://books.google.nl/books?id=O2hYAAAAcAAJ&pg=PR5#v=onepage&q&f=false
Mean distance: 19.33 (cluster 2) | S | N | B | C | P |
Cross-listing: Anatomy Tree
Parents
Sign in to add mentor| Johann Nepomuk von Raimann | grad student | 1824 | Vienna University | |
| (Mutationes membranae intestinorum villosae in phthisi tuberculosa et febri nervosa) | ||||
Children
Sign in to add trainee| Karl Freiherr von Rokitansky | post-doc | 1828-1831 | Vienna University (ID Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bejanyan N, Vlasova-St Louis I, Mohei H, et al. (2021) Cytomegalovirus-Specific Immunity Recovers More Slowly after Cord Blood Transplantation Compared with Matched Sibling Donor Allogeneic Transplantation. Transplantation and Cellular Therapy. 27: 187.e1-187.e4 |
| Okoev G, Weisdorf DJ, Wagner JE, et al. (2021) Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant. Bone Marrow Transplantation |
| Bi X, Carabasi M, Filicko-Ohara J, et al. (2021) The Two-Step Haploidentical Allogeneic Stem Cell Transplant Approach Results in Rapid Engraftment and Excellent Outcomes in Patients ≥70 Years Old Transplantation and Cellular Therapy. 27: S436 |
| Yang Y, Gergis U, Carabasi M, et al. (2021) The Two-Step Allogeneic Stem Cell Transplant Approach Results in Rapid Engraftment and Excellent Outcomes in Patients with Lymphoid Malignancies Transplantation and Cellular Therapy. 27: S419 |
| Ferdjallah A, Long S, Defor TE, et al. (2021) CYP2B6 Variants in Cyclophosphamide Metabolism and the Incidence of Hemorrhagic Cystitis in Fanconi Anemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation Transplantation and Cellular Therapy. 27: S219 |
| Gupta AO, Wagner JE. (2020) Umbilical Cord Blood Transplants: Current Status and Evolving Therapies. Frontiers in Pediatrics. 8: 570282 |
| El Jurdi N, Rogosheske J, DeFor T, et al. (2020) Prophylactic foscarnet for human herpesvirus 6: effect on hematopoietic engraftment after reduced intensity conditioning umbilical cord blood transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation |
| Brazauskas R, Scigliuolo GM, Wang HL, et al. (2020) Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease. Blood |
| Wagner JE, Ballen KK, Zhang M, et al. (2020) Comparison of Haploidentical Related Donor with Post-Transplant Cyclophosphamide (PTCy) and Umbilical Cord Blood (UCB) Transplantation after Myeloablative Conditioning for Hematological Malignancy Biology of Blood and Marrow Transplantation. 26 |
| Wagner JE, Brunstein CG, McKenna DH, et al. (2020) Mgta-456, a Cell Therapy Utilizing Expansion of CD34+ Hematopoietic Stem Cells (HSC), Improves HLA Matching for Adult Recipients, Promotes Faster Hematopoietic Recovery and Enables Uniform Engraftment with Less Acute Graft-Vs-Host Disease (GVHD) Biology of Blood and Marrow Transplantation. 26: S205-S206 |